Effect of obesity on patient-reported outcomes in sarcoidosis

International Journal of Tuberculosis and Lung Disease

Volumn 17, Issue 4, 2013, Pages 559-564

  Gvozdenovic, B S ^a   Mihailovic Vucinic, V ^b,c   Vukovic, M ^d   Lower, E E ^e   Baughman, R P ^b,c   Dudvarski Ilic, A ^b,c   Zugic, V ^b,c   Popevic, S ^b   Videnovic Ivanov, J ^b   Filipovic, S ^b   Stjepanovic, M ^b   Omcikus, M ^b  

^a PPD Serbia ^*  (Serbia)

^b Clinic for Psychiatry CCS   (Serbia)

^c UNIVERSITY OF BELGRADE   (Serbia)

^d Health Center Valjevo   (Serbia)

^e UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

Author keywords

Body mass index; Dyspnoea; Fatigue; Health status; Obesity; Patientreported outcomes; Sarcoidosis

Indexed keywords

METHOTREXATE; PREDNISONE;

ADULT; ARTICLE; BODY MASS; CASE CONTROL STUDY; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; DISEASE ASSOCIATION; DYSPNEA; FATIGUE; FATIGUE SCALE; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HEALTH STATUS; HUMAN; LUNG SARCOIDOSIS; MAJOR CLINICAL STUDY; MALE; OBESITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SCORING SYSTEM; SPIROMETRY; ST. GEORGE RESPIRATORY QUESTIONNAIRE; SYMPTOMATOLOGY;

ADULT; BODY MASS INDEX; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; DYSPNEA; FATIGUE; FEMALE; FORCED EXPIRATORY VOLUME; HEALTH STATUS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LOGISTIC MODELS; LUNG; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OBESITY; ODDS RATIO; PREDICTIVE VALUE OF TESTS; PROGNOSIS; QUESTIONNAIRES; RISK FACTORS; SARCOIDOSIS, PULMONARY; SERBIA; SPIROMETRY; VITAL CAPACITY;

EID: 84875423592     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: 10.5588/ijtld.12.0665     Document Type: Article

References (27)

1. Gvozdenovic B S, Mihailovic-Vucinic V, Videnovic J, Zugic V, Ilic-Dudvarski A, Filipovic S. Quality of life and health status in sarcoidosis patients. Chapter 6. In: Hoffmann E C, ed. Health-related quality of life. New York, NY, USA: Nova Science Publishers, 2009: pp 119-13-2.
2. Hunninghake G W, Costabel U, Ando M, et al. ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders. Sarcoidosis Vasc Diffuse Lung Dis 1999; 16: 149-17-3.
3. Bauer M P, Brouwer P A, Smit V T, Tamsma J T. The challenges of extrapulmonary presentations of sarcoidosis: a case report and review of diagnostic strategies. Eur J Intern Med 2007; 18: 152-15-4.
4. Sharma O P. Fatigue and sarcoidosis. Eur Respir J 1999; 13: 713-71-4.
5. Michielsen H J, Peros-Golubicic T, Drent M, de Vries J. Relationship between symptoms and quality of life in a sarcoidosis population. Respiration 2007; 74: 401-40-5.
6. Bradley C. Importance of differentiating health status from quality of life. Lancet 2001; 357: 7-8.
7. Belojević G, Marić-Zivković J. Sarcoidosis and obesity. Med Pregl 2005; 58 (Suppl 1): 44-4-5.
8. Vesely D L. Hypothalamic sarcoidosis: a new cause of morbid obesity. South Med J 1989; 82: 758-76-1.
9. World Health Organization. Obesity: preventing and managing the global epidemic. Report of a WHO consultation on obesity. WHO Technical Report Series 894. Geneva, Switzerland: WHO, 200-0.
10. Chalder T, Berelowitz G, Pawlikowska T, et al. Development of a fatigue scale. J Psychosom Res 1993; 37: 147-15-3.
11. Mahler D A, Weinberg D H, Wells C K, Feinstein A R. The measurement of dyspnoea: contents, interobserver agreement, and physiologic correlates of two new clinical indexes. Chest 1984; 85: 751-75-8.
12. Jones P W, Quirk F H, Baveystock C M, Littlehohns P. A selfcomplete measure of health status for chronic airfl ow limitation. The St George's Respiratory Questionnaire. Am Rev Respir Dis 1992; 145: 1321-132-7.
13. Miller M R, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J 2005; 26: 319-33-8.
14. Victorson D E, Cella D, Judson M A. Quality of life evaluation in sarcoidosis: current status and future directions. Curr Opin Pulm Med 2008; 14: 470-47-7.
15. Wirnsberger R M, Drent M, Hekelaar N, et al. Relationship between respiratory muscle function and quality of life in sarcoidosis. Eur Respir J 1997; 10: 1450-145-5.
16. Cox C E, Donohue J F, Brown C D, Kataria Y P, Judson M A. Health-related quality of life of persons with sarcoidosis. Chest 2004; 125: 997-100-4.
17. Gvozdenovic B. Assessment of clinical outcomes infl uence on health status in sarcoidosis patients. PhD thesis. Belgrade, Serbia: Belgrade University, 201-0.
18. Drent M, Wirnsberger R M, de Vries J, van Dieijen-Visser M P, Wouters E F, Schols A M. Association of fatigue with an acute phase response in sarcoidosis. Eur Respir J 1999; 13: 718-72-2.
19. Boots A W, Drent M, Swennen E L, Moonen H J, Bast A, Haenen G R. Antioxidant status associated with infl ammation in sarcoidosis: a potential role for antioxidants. Respir Med 2009; 103: 364-73-2.
20. Spruit M A, Thomeer M J, Gosselink R, et al. Skeletal muscle weakness in patients with sarcoidosis and its relationship with exercise intolerance and reduced health status. Thorax 2005; 60: 32-3-8.
21. Baydur A, Alavy B, Nawathe A, Liu S, Louie S, Sharma O P. Fatigue and plasma cytokine concentrations at rest and during exercise in patients with sarcoidosis. Clin Respir J 2011; 5: 156-16-4.
22. Riazi A, Shakoor S, Dundas I, Eiser C, McKenzie S A. Healthrelated quality of life in a clinical sample of obese children and adolescents. Health Qual Life Outcomes 2010; 8: 13-4.
23. Mannucci E, Petroni M L, Villanova N, et al. Clinical and psychological correlates of health-related quality of life in obese patients. Health Qual Life Outcomes 2010; 8: 9-0.
24. Baydur A, Alsalek M, Louie S G, Sharma O P. Respiratory muscle strength, lung function, and dyspnoea in patients with sarcoidosis. Chest 2001; 120: 102-10-8.
25. Baughman R P, Winget D B, Lower E E. Methotrexate is steroid sparing in acute sarcoidosis: results of a double blind, randomized trial. Sarcoidosis Vasc Diffuse Lung Dis 2000; 17: 60-6-6.
26. de Kleijn W P, Elfferich M D, de Vries J, et al. Fatigue in sarcoidosis: American versus Dutch patients. Sarcoidosis Vasc Diffuse Lung Dis 2009; 26: 92-9-7.
27. de Vries J, Rothkrantz-Kos S, Dieijen-Visser M P, Drent M. The relationship between fatigue and clinical parameters in pulmonary sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2004; 21: 127-13-6.